Latest The City of London Migraine Clinic Stories
SAN DIEGO, Feb. 18 /PRNewswire/ -- Zogenix, Inc. ("Zogenix"), a private, specialty pharmaceutical company, announced that the U.S.
New research looks at whether a gene variant may affect the link between migraine and stroke or heart attacks. The study is published in the February 17, 2009, print issue of NeurologyÂ®, the medical journal of the American Academy of Neurology.
New research links larger waistlines to an increased risk of migraine headaches. The findings will be released in May at the American Academy of Neurologyâ€™s Annual meeting.
Overweight people who are between the ages of 20 and 55 may have a higher risk of experiencing migraine headaches.
A new study published in Value in Health reviews the economic burden of migraine in the U.S. and recent clinical findings of the health risks of this neurological condition.
A new survey suggests, that despite the pervasiveness of migraine and other headache disorders in the US, most individuals suffering a severe headache steer clear of emergency departments.
MOUNTAIN VIEW, Calif., Jan. 26 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc.
Minster Pharmaceuticals, a drug development company, has announced positive results from its Phase II trial in Denmark of tonabersat in the prevention of migraine with aura.
ESSEX, United Kingdom, Oct.
Allergan, a multi-specialty healthcare company, has completed a top-line analysis of its two Phase III clinical trials exploring the use of Botox for the prophylactic treatment of headache in adults suffering from chronic migraine.